Skip to main content
Seema Bhat, MD, Hematology, Columbus, OH

SeemaAliBhatMD

Hematology • Columbus, OH

Physician

Join to view full profile

Dr. Bhat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bhat's full profile

Already have an account?

  • Office

    460 W 10th Ave
    Columbus, OH 43210
    Phone+1 614-293-3196
    Fax+1 614-293-4812

Summary

  • Dr. Seema A. Bhat is an Oncologist in Columbus, OH and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Wexner Medical Center. She received her medical degree from Government Medical College of Jammu and Kashmir and has been in practice for 19 years. She also speaks multiple languages, including Kashmiri, Urdu and Hindi. She specializes in hematologic/Medical oncology and is experienced in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, cold agglutinin disease, Autoimmune hemolytic anemia, Lymphomas and related disorders.

Education & Training

  • University at Buffalo
    University at BuffaloFellowship, Hematology and Medical Oncology, 2008 - 2011
  • University at Buffalo
    University at BuffaloResidency, Internal Medicine, 2004 - 2008
  • Government Medical College of Jammu and Kashmire
    Government Medical College of Jammu and KashmireClass of 1999

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 2011 - 2020
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Resistance to Acalabrutinib in CLL Is Mediated Primarily By BTK Mutations
    Seema A. Bhat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Final Results of a Phase 2 Trial of Early Intervention Ibrutinib with Vaccinations in Patients with Asymptomatic, High-Risk CLL
    Seema A. Bhat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Ibrutinib Treatment in CLL Patients Improves T Cell Function and Blinatumomab Redirected Cytotoxicity
    Seema A. Bhat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Committees

  • Chairperson, P&T Comittee Roswell Park Comphrensive Cancer center 2014 - 2017

Professional Memberships

Other Languages

  • Urdu

Dr. Seema Bhat, Dr. Seema Bhat, MD, Dr. S Bhat, Dr. Seema Ali Bhat